Presynaptic modulation of synaptic inhibition onto hippocampal pyramidal neurons
- Institution
- STATE UNIVERSITY OF NEW YORK AT ALBANY, NY
- Principal investigator
- Annalisa Scimemi
- Funding
- $565K
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Throughout the hippocampus, pyramidal cells integrate excitatory and inhibitory inputs from a diverse population of interneurons. These cells provide feedforward and feedback inhibition onto CA1 pyramidal cells, and can be recruited via glutamate spillover, a phenomenon that describes non-synaptic actions of glutamate diffusing away from the synaptic cleft. The prevailing view, at present, is that glutamate spillover leads to activation of presynaptic group III metabotropic (mGluRIII) glutamate receptors, which inhibit synaptic excitation and inhibition only onto interneurons, not CA1 pyramidal cells. Against this interpretation, our preliminary data indicates that spillover activation of mGluRIII receptors also exists at inhibitory synapses formed onto CA1 pyramidal cells, when experiments are performed under experimental conditions that mimic more closely the ionic composition of the cerebrospinal fluid. The main goals in this application are: (i) to determine how mGluRIII activation via glutamate spillover varies between excitatory and inhibitory inputs, and among inhibitory inputs formed by different classes of interneurons; (ii) to identify the intracellular signaling mechanisms that couple mGluRIII activation to neurotransmitter release; (iii) the determine the sub-cellular location of different type of mGluRIII receptors at different types of inhibitory synapses onto CA1 pyramidal cells; (iv) to determine how mGluRIII activation alters encoding of spatial information by hippocampal CA1 place cells in vivo. The proposed experiments capitalize on in vitro and in vivo electrophysiology, and EM approaches. These findings will generate new information on the operating principles of neuronal circuits involved in spatial map representation and will contribute to the future development of effective strategies to treat disease states associated with hippocampal neural circuit dysfunction, like epilepsy and autism spectrum disorder.
LOADING MOONBASE SCORE
Questions for STATE UNIVERSITY OF NEW YORK AT ALBANY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · State University of New York at AlbanyNot yet scored
Evident SLIDEVIEW VS200 Slide Scanner
Annalisa Scimemi · $278K · 2025–2026
- NIH · State University of New York at Albany54
N6-Methyladenosine Methylome in Duchenne Muscular Dystrophy
Bijan K Dey · $200K · 2023–2026
- NIH · State University of New York at Albany52
Animal testing of RNA aptamers as ALS drug candidate
Li Niu · $364K · 2022–2026